Alpha 2.0
Login Register
» Journals » BMC Med

Bmc Medicine

BMC Medicine is a peer-reviewed open-access journal that publishes high-quality research articles, reviews, and commentaries across all areas of medical science. With a focus on advancing medical knowledge and improving patient care, the journal covers a wide range of topics including clinical trials, epidemiology, genetics, and healthcare policy. BMC Medicine aims to provide a platform for researchers and clinicians to share their findings and contribute to the global medical community.
Details
Abbr. BMC Med
Publisher Biomed Central
Start 2003
End Continuing
e-ISSN 1741-7015
Country United Kingdom
Language English
Specialty General Medicine
Metrics
h-index / Ranks: 859 186
SJR / Ranks: 727 2711
CiteScore / Ranks: 691 14.20
JIF / Ranks: 519 9.3
Recent Articles
1.
The interdependence of mid-trimester blood pressure and glucose levels in shaping fetal growth and neonatal outcomes: implications for risk-benefit assessment and co-management
Lv L, Yang J, Li L, Huang C, Shi H, Fang Y, et al.
BMC Med . 2025 Mar; 23(1):161. PMID: 40087732
Background: Maternal hypertension and hyperglycemia are closely related but have distinct impacts on fetal growth and are managed independently. How the interdependence of blood pressure (BP) and glucose levels quantitatively...
2.
Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer
Wang S, Sun L, Shih Y, Lu T, Chen Y, Hsu S, et al.
BMC Med . 2025 Mar; 23(1):160. PMID: 40087652
Background: Lenvatinib plus pembrolizumab has demonstrated improved survival compared with doxorubicin or paclitaxel monotherapy in patients with advanced or recurrent endometrial cancers (ECs). However, response rates to monotherapy are poor...
3.
Reduced risks of influenza-associated hospitalization and complications following vaccination among over 2 million older individuals: a nationwide study using target trial emulation framework
Peng Z, Hua Y, Huang W, Wu J, Ou H
BMC Med . 2025 Mar; 23(1):157. PMID: 40082958
Background: Current evidence on influenza vaccine effectiveness (VE), which is predominately derived from small high-risk older populations and focuses on specific influenza-related complications, might not be generalizable to real-world older...
4.
Prevalence, trends, and geographic distribution of human papillomavirus infection in Chinese women: a summative analysis of 2,728,321 cases
Han S, Lin M, Liu M, Wu S, Guo P, Guo J, et al.
BMC Med . 2025 Mar; 23(1):158. PMID: 40082952
Background: Cervical cancer (CC), primarily caused by human papillomavirus (HPV) infection, remains a significant global health concern. We aimed to comprehensively investigate the epidemiological status of HPV in China. Methods:...
5.
Differences in plasma metabolome between non-Hispanic White and non-Hispanic Black women
Pourali G, Li L, Jeon M, Luo J, Luo C, Toriola A
BMC Med . 2025 Mar; 23(1):159. PMID: 40082900
Background: To understand potential racial differences in disease susceptibility and develop targeted prevention strategies, it is essential to establish biological differences between racial groups in healthy individuals. However, knowledge about...
6.
Risk, determinants, and persistence of long-COVID in a population-based cohort study in Catalonia
Kogevinas M, Karachaliou M, Espinosa A, Iraola-Guzman S, Castano-Vinyals G, Delgado-Ortiz L, et al.
BMC Med . 2025 Mar; 23(1):140. PMID: 40082863
Background: Long-COVID has mostly been investigated in clinical settings. We aimed to assess the risk, subtypes, persistence, and determinants of long-COVID in a prospective population-based study of adults with a...
7.
Modifiable risk factors of vaccine hesitancy: insights from a mixed methods multiple population study combining machine learning and thematic analysis during the COVID-19 pandemic
Ebrahimi O, Sandbakken E, Moss S, Johnson S, Hoffart A, Bauermeister S, et al.
BMC Med . 2025 Mar; 23(1):155. PMID: 40075423
Background: Vaccine hesitancy, the delay in acceptance or reluctance to vaccinate, ranks among the top threats to global health. Identifying modifiable factors contributing to vaccine hesitancy is crucial for developing...
8.
Hypoxia tolerance determine differential gelsenicine-induced neurotoxicity between pig and mouse
Huang C, Zuo M, Qi X, Gong M, Xu W, Meng S, et al.
BMC Med . 2025 Mar; 23(1):156. PMID: 40075370
Background: Gelsemium elegans (G. elegans) is widely recognized as one of the most toxic plants globally, particularly harmful to humans. Some reports indicate that it is non-toxic to pigs and...
9.
Modifications to the National Early Warning Score 2: a Scoping Review
Riccalton V, Threlfall L, Ananthakrishnan A, Cong C, Milne-Ives M, Le Roux P, et al.
BMC Med . 2025 Mar; 23(1):154. PMID: 40069742
Background: The National Early Warning Score 2 (NEWS2) has been adopted as the standard approach for early detection of deterioration in clinical settings in the UK, and is also used...
10.
International evidence-based recommendations for polycystic ovary syndrome in adolescents
Pena A, Witchel S, Boivin J, Burgert T, Ee C, Hoeger K, et al.
BMC Med . 2025 Mar; 23(1):151. PMID: 40069730
Background: During adolescence, accurate diagnostic criteria and/or identification of adolescents "at risk" of polycystic ovary syndrome (PCOS) are critical to establish appropriate screening, treatment, and lifelong health plans. The 2023...